- Home
- PSNL
PSNL
Personalis Inc.
as of 03-13-2026 4:00pm EST
$6.72
+$0.14
+2.09%
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 729.1M | IPO Year: | 2019 |
| Target Price: | $11.50 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.91 | EPS Growth: | 33.58 |
| 52 Week Low/High: | $2.83 - $11.50 | Next Earning Date: | 05-18-2026 |
| Revenue: | $69,648,000 | Revenue Growth: | -17.69% |
| Revenue Growth (this year): | 16.94% | Revenue Growth (next year): | 36.58% |
| P/E Ratio: | -7.23 | Index: | N/A |
| Free Cash Flow: | -79450000.0 | FCF Growth: | N/A |
AI-Powered PSNL Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 78.34%
78.34%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Personalis Inc. (PSNL)
Tachibana Aaron
Sell
CFO AND COO
PSNL Jan 22, 2026
Avg Cost/Share
$11.50
Shares
1,201
Total Value
$13,811.50
Owned After
164,458
SEC Form 4
Tempus Labs, Inc.
Buy
10% Owner
PSNL Dec 22, 2025
Avg Cost/Share
$8.93
Shares
28,000
Total Value
$250,040.00
Owned After
13,039,067
SEC Form 4
Tempus Labs, Inc.
Buy
10% Owner
PSNL Dec 19, 2025
Avg Cost/Share
$8.39
Shares
29,641
Total Value
$248,687.99
Owned After
13,039,067
SEC Form 4
Tempus Labs, Inc.
Buy
10% Owner
PSNL Dec 18, 2025
Avg Cost/Share
$7.91
Shares
31,430
Total Value
$248,611.30
Owned After
13,039,067
SEC Form 4
Tempus Labs, Inc.
Buy
10% Owner
PSNL Dec 17, 2025
Avg Cost/Share
$7.86
Shares
31,650
Total Value
$248,769.00
Owned After
13,039,067
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Tachibana Aaron | PSNL | CFO AND COO | Jan 22, 2026 | Sell | $11.50 | 1,201 | $13,811.50 | 164,458 | |
| Tempus Labs, Inc. | PSNL | 10% Owner | Dec 22, 2025 | Buy | $8.93 | 28,000 | $250,040.00 | 13,039,067 | |
| Tempus Labs, Inc. | PSNL | 10% Owner | Dec 19, 2025 | Buy | $8.39 | 29,641 | $248,687.99 | 13,039,067 | |
| Tempus Labs, Inc. | PSNL | 10% Owner | Dec 18, 2025 | Buy | $7.91 | 31,430 | $248,611.30 | 13,039,067 | |
| Tempus Labs, Inc. | PSNL | 10% Owner | Dec 17, 2025 | Buy | $7.86 | 31,650 | $248,769.00 | 13,039,067 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 26, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 26, 2026 · 100% conf.
AI Prediction BUY
1D
+8.00%
$9.75
Act: +0.00%
5D
+20.87%
$10.91
Act: -5.20%
20D
+21.99%
$11.02
Price: $9.03 Prob +5D: 100% AUC: 1.000
0001193125-26-076553
8-K
0001527753false00015277532026-02-262026-02-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026
Personalis, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-38943
27-5411038
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
6600 Dumbarton Circle Fremont, California
94555
(Address of Principal Executive Offices)
(Zip Code)
(650) 752-1300 Registrant’s Telephone Number, Including Area Code Not Applicable (Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
PSNL
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On February 26, 2026, Personalis, Inc. issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2025. The full text of the press release is furnished as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits
Exhibit Number
Description
99.1
Press release of Personalis, Inc., dated February 26, 2026.
104
Cover Page Interactive Data File (embedded within the inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: February 26, 2026
Personalis, Inc.
By:
/s/ Aaron Tachibana
Aaron Tachibana
Chief Financial Officer and Chief Operating Officer
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 8, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 8, 2026 · 100% conf.
AI Prediction BUY
1D
+8.00%
$9.75
Act: +0.00%
5D
+20.87%
$10.91
Act: -5.20%
20D
+21.99%
$11.02
Price: $9.03 Prob +5D: 100% AUC: 1.000
0001193125-26-007037
8-K
false000152775300015277532026-01-082026-01-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2026
Personalis, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-38943
27-5411038
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
6600 Dumbarton Circle Fremont, California
94555
(Address of Principal Executive Offices)
(Zip Code)
(650) 752-1300 Registrant’s Telephone Number, Including Area Code Not Applicable (Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
PSNL
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On January 8, 2026, Personalis, Inc. issued a press release announcing certain preliminary financial and operational results for the quarter and fiscal year ended December 31, 2025. The full text of the press release is furnished as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits
Exhibit Number
Description
99.1
Press release of Personalis, Inc., dated January 8, 2026.
104
Cover Page Interactive Data File (embedded within the inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: January 8, 2026
Personalis, Inc.
By:
/s/ Aaron Tachibana
Aaron Tachibana
Chief Financial Officer and Chief Operating Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 4, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 4, 2025
0001193125-25-264690
8-K
false000152775300015277532025-11-042025-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2025
Personalis, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-38943
27-5411038
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
6600 Dumbarton Circle Fremont, California
94555
(Address of Principal Executive Offices)
(Zip Code)
(650) 752-1300 Registrant’s Telephone Number, Including Area Code Not Applicable (Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
PSNL
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On November 4, 2025, Personalis, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2025. The full text of the press release is furnished as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits
Exhibit Number
Description
99.1
Press release of Personalis, Inc., dated November 4, 2025.
104
Cover Page Interactive Data File (embedded within the inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: November 4, 2025
Personalis, Inc.
By:
/s/ Aaron Tachibana
Aaron Tachibana
Chief Financial Officer and Chief Operating Officer
Latest Personalis Inc. News
PSNL Breaking Stock News: Dive into PSNL Ticker-Specific Updates for Smart Investing
Compare PSNL vs Leading Stocks
See how PSNL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PSNL Personalis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.